Characterisation and antimicrobial resistance of sepsis pathogens in neonates born in tertiary care centres in Delhi, India: a cohort study
Autor: | Chandra Kumar Natarajan, Vikas Manchanda, Manorama Deb, Longjam Shilhenba Meite, Sony K. Varghese, Arti Kapil, Kailash Chandra, Shuchita Gupta, Jincymol George, Anju Sinha, Malabika Roy, Deb S. K. Prakash, Nidhi Goel, Madan Singh, Neelam Manral, Vandana Rani, Aanchal Wadhwa, K C Aggarwal, Vikas Dabbas, Mamta Dhoopar, Manoj Modi, Harish Chellani, Anni Therasa, Steffi Wilson, Pratibha Gupta, Jenifer Chinnu Abraham, Rajni Gaind, Deepak Kumar, Sugandha Arya, D. Vimala, Kunj Bihari Gupta, Simi P. Johny, Sreenivas Vishnubhatla, Somi S. Suresh, Manju Saksena, Kaustav Banerjee, Josmi Philip, Manjari Chaudhari, Dhanya Alex, Ann Rainu Jose, Benu Varghese, Abraham Mary, Abhinov Kher, K. S. Seena, Rosemol Mathachan, Purva Mathur, Kumar Surinder, Siddarth Ramji, Anjali Thareja, Angel George, Joginder Singh Nim, Sreemol Sarasan, S. K. Prakash, Vidya Kumari, Akhilesh Kumar, Deeksha Mittal, Mamta Jajoo, Simi Thomas, Ashok K. Deorari, Asha Susan Philip, Mariya Thomas, Deepali Agarwal, M. S. Prasad, Vinod K. Paul, Suman Chaurasia, Shyam Narayan Yadav, Sant Lal Meenakshi, Dona Jose, Charu, Neeraj Gupta, Reeta Rasaily, Rimjhim Johri, Hitender Gautam, Ashok Kumar, Honey Mary James, Anil Mor, M. Jeeva Sankar, Aggarwal, Manish Sethi, Chander Prakash Yadav, Surinder Kumar, Mitali Bhardwaj, Vasantha Muthuswamy, Nisha Rani, Sumita Saluja, Zulfikar Ali Bhuttoo, Shub Darshan, Suman Singh, Ramesh Agarwal, Anu Thukral, Vandana Gulati, Ashish Jain |
---|---|
Rok vydání: | 2016 |
Předmět: |
Male
Methicillin-Resistant Staphylococcus aureus medicine.medical_specialty Staphylococcus India Microbial Sensitivity Tests law.invention Cohort Studies Tertiary Care Centers Sepsis 03 medical and health sciences 0302 clinical medicine Antibiotic resistance law Klebsiella 030225 pediatrics Internal medicine Drug Resistance Bacterial Gram-Negative Bacteria Infant Mortality Epidemiology Escherichia coli Humans Medicine 030212 general & internal medicine Cross Infection Acinetobacter biology Neonatal sepsis business.industry Incidence (epidemiology) Infant Newborn Infant General Medicine Delivery Obstetric biology.organism_classification medicine.disease Intensive care unit Drug Resistance Multiple Hospitals Anti-Bacterial Agents Female business Cohort study |
Zdroj: | The Lancet Global Health. 4:e752-e760 |
ISSN: | 2214-109X |
DOI: | 10.1016/s2214-109x(16)30148-6 |
Popis: | Background: Sepsis is one of the most common causes of neonatal deaths globally. Most sepsis-related deaths occur in low-income and middle-income countries, where the epidemiology of neonatal sepsis remains poorly understood. Most of these countries lack proper surveillance networks, hampering accurate assessment of the burden of sepsis, implementation of preventive measures, and investment in research. We report results of neonates born in hospital from a multicentre collaboration on neonatal sepsis. Methods: In this cohort study, dedicated research teams prospectively followed up neonates born in one of three tertiary care centres in Delhi, India (Vardhaman Mahavir Medical College, Maulana Azad Medical College, and All India Institute of Medical Sciences [coordinating centre]) and subsequently admitted to the intensive care unit. Neonates were followed up daily until discharge or death. On clinical suspicion, neonates underwent sepsis work-up including blood cultures. The isolated organisms were identified and tested for antimicrobial susceptibility. We defined Gram-negative isolates resistant to any three of five antibiotic classes (extended-spectrum cephalosporins, carbapenems, aminoglycosides, fluoroquinolones, and piperacillin-tazobactam) as multidrug resistant. Findings: 13 530 neonates of 88 636 livebirths were enrolled between July 18, 2011, and Feb 28, 2014. The incidence of total sepsis was 14·3% (95% CI 13·8–14·9) and of culture-positive sepsis was 6·2% (5·8–6·6). Nearly two-thirds of total episodes occurred at or before 72 h of life (defined as early onset; 1351 [83%] of 1980). Two-thirds (645 [64%]) of 1005 isolates were Gram-negative including, Acinetobacter spp (22%), Klebsiella spp (17%), and Escherichia coli (14%). The pathogen mix in early-onset sepsis did not differ from that of late-onset sepsis (ie, after 72 h). High rates of multidrug resistance were observed in Acinetobacter spp (181/222, 82%), Klebsiella spp (91/169, 54%), and Escherichia coli (52/137, 38%) isolates. Meticillin resistance prevailed in 61% (85/140) of coagulase-negative staphylococci and 38% (43/114) of Staphylococcus aureus isolates. Nearly a quarter of the deaths were attributable to sepsis. The population-attributable risks of mortality were 8·6% in culture-negative sepsis, 15·7% in culture-positive sepsis by multidrug-resistant organisms, and 12·0% in culture-positive sepsis by non-multidrug-resistant organisms. Interpretation: The high incidence of sepsis and alarming degree of antimicrobial resistance among pathogens in neonates born in tertiary hospitals underscore the need to understand the pathogenesis of early-onset sepsis and to devise measures to prevent it in low-income and middle-income countries. Funding: Indian Council of Medical Research |
Databáze: | OpenAIRE |
Externí odkaz: |